Product Code: SR1323A608_Report
The global digital PCR market size reached US$ 4.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.9 Billion by 2028, exhibiting a growth rate (CAGR) of 10.5% during 2023-2028.
Digital polymerase chain reaction, or digital PCR (dPCR), refers to an end-point, high-throughput absolute quantitative analytics that assists in measuring the DNA or RNA count in a given sample in a precise and sensitive way. Designed for absolute quantification and the analysis of minority sequences against a background of similar majority sequences, it is semi-quantitative as the amplified product is detected by agarose gel electrophoresis. When compared to its traditional counterparts, digital PCR uses a wide range of methods, such as droplet-based, chip-based, and beaming dPCR, to facilitate diverse applications. As a result, dPCR methods are extensively utilized in basic and diagnostic research, such as human genetic testing, pathogen detection, infectious disease testing and forensic sciences.
Digital PCR Market Trends:
- The market is primarily driven by the increasing healthcare expenditure on molecular diagnosis across the globe. This can be attributed to the rising prevalence of numerous diseases, such as genetic disorders, COVID-19, lung cancer, brain tumors, breast cancer and blood cancer. In addition to this, the escalating consumer demand for early diagnosis and treatment has resulted in extensive research and development (R&D) focusing on genetic technologies, which, in turn, is propelling the market. Besides this, continual technological advancements in PCR technologies, along with the launch of innovative devices for droplet, chip-based, beam, and crystal dPCR by major market players, are creating a positive outlook for the market. The market is further driven by the growing adoption of dPCR devices in reference laboratories for detecting genetic mutations and identifying pathogens, thereby leading to a higher product uptake. Some of the other factors that are contributing to the market growth include favorable initiatives undertaken by governmental and federal agencies across the globe, a paradigm shift from plant-derived to genome-based drug discovery, and augmenting product applications in food microbiology and veterinary medicine.
Key Market Segmentation:
- IMARC Group provides an analysis of the key trends in each sub-segment of the global digital PCR market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, technology and application.
Breakup by Product Type:
- Digital PCR Equipment
- Consumables and Reagents
- Software and Services
Breakup by Technology:
- Droplet Digital PCR
- BEAMing Digital PCR
Breakup by Application:
- Clinical Diagnostics
- Forensics
- Research
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
- The competitive landscape of the industry has also been examined along with the profiles of the key players being Avance Biosciences Inc., Bio-Rad Laboratories Inc., Danaher Corporation, JN Medsys, OPTOLANE Technologies Inc., QIAGEN, SAGA Diagnostics AB, Standard BioTools Inc., Stilla Technologies, Sysmex Corporation and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
- How has the global digital PCR market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global digital PCR market?
- What are the key regional markets?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global digital PCR market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Digital PCR Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Digital PCR Equipment
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Consumables and Reagents
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Droplet Digital PCR
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 BEAMing Digital PCR
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Application
- 8.1 Clinical Diagnostics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Forensics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Research
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Avance Biosciences Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Bio-Rad Laboratories Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Danaher Corporation
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 JN Medsys
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 OPTOLANE Technologies Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 QIAGEN
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 SAGA Diagnostics AB
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Standard BioTools Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.9 Stilla Technologies
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Sysmex Corporation
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Thermo Fisher Scientific Inc.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis